Gilead buys YM for $510m
Thursday, December 20, 2012 - 06:30
in Mathematics & Economics
Deal gives Gilead access to Janus kinase inhibitor CYT387 for the treatment of myelofibrosis
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via